Vivior is able to offer added value for myopia management by
recording of the objective visual behavior to determine myopia risk factors.
Article on the user friendliness of Vivior's system as shown in a multicenter study with 129 patients.
At ARVO 2019 in Vancouver, the most significant and most respected eye and vision research organization in the world, Cafer Tanrıverdi, Istanbul Medipol University Ophthalmology Department, Turkey, has presented first results from our clinical trials on the Objective Measurement of Photopic Illuminance Rate in Daily Life of Progressive Myopic Children.
At ARVO 2019 in Vancouver, the most significant and most respected eye and vision research organization in the world, Burcu Nurozler Tabakçı, Medipol Hospital, Istanbul, Turkey, has presented first results from our clinical trials on progressive myopia.
Arthur Cummings, the chairman of the Vivior Medical Advisory Board, won the Best Paper in Session Award at the meeting of the American Society of Cataract and Refractive Surgery (ASCRS) in Washington DC.
Vivior has presented at the Ophthalmology Futures European Forum 2017 in Lisbon.
